Related by context. Frequent words. (Click for all words.) 84 RECIST 79 evaluable patients 75 evaluable 67 cytogenetic response 65 mg kg dose 65 neoadjuvant chemotherapy 64 median PFS 64 free survival PFS 64 tumor shrinkage 63 Secondary endpoints include 62 FOLFOX 62 tumor regression 62 mcg kg 62 mg BID 61 neoadjuvant 61 chemoradiation 61 DAS# [002] 61 FOLFIRI 61 nab paclitaxel 61 annualized relapse 60 mg QD 60 Secondary endpoints 60 peginterferon 60 Secondary endpoints included 60 hematologic 60 mg/m2 60 peginterferon alfa 2a 60 mitoxantrone 60 sustained virologic response 59 PROMACTA 59 Median survival 59 dose cohorts 59 dasatinib 59 dacarbazine 59 composite endpoint 59 adalimumab 59 plus methotrexate 58 tumor recurrence 58 peg IFN 58 decitabine 58 plus ribavirin 58 HER2 positive metastatic breast 58 virologic response 58 secondary efficacy endpoints 58 FDG PET 58 metastatic renal cell carcinoma 58 plus prednisone 58 peripheral blood mononuclear 58 peginterferon alfa 2b 57 epithelial ovarian cancer 57 IMGN# 57 liver metastases 57 ≥ 57 relapsed multiple myeloma 57 febrile neutropenia 57 relapsed refractory multiple myeloma 57 xenograft models 57 nephrectomy 57 creatinine clearance 57 serum phosphorus 57 imatinib 57 relapsed refractory 57 Taxotere ® 57 refractory multiple myeloma 57 nilotinib 57 interferon alfa 57 COPAXONE R 56 noninferiority 56 secondary endpoint 56 sunitinib 56 nonresponders 56 dose escalation 56 % CI #.#-#.# [006] 56 log# 56 glioblastoma multiforme GBM 56 placebo controlled clinical 56 DMARD 56 undetectable viral load 56 tumor lysis syndrome 56 pegylated interferon 56 administered subcutaneously 56 distant metastases 56 azacitidine 56 unresectable 56 vandetanib 55 HCV genotype 1 55 bortezomib 55 adjuvant chemotherapy 55 n = 55 HER2 negative 55 limiting toxicity 55 temsirolimus 55 fluorouracil 55 eGFR 55 plus gemcitabine 55 tolerated dose MTD 55 confidence interval CI 55 histologic 55 diagnosed multiple myeloma 55 TORISEL 55 STELARA